[1]
L. Dalle Carbonare, F. Bertoldo, and V. Lo Cascio, “Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project”, Reumatismo, vol. 61, no. 1, pp. 54-64, 1.